Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial: An update. Impact of response to prior chemotherapy (RTPC) on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback